Benzphet

Article Contents ::

Details About Generic Salt ::  Benzphet

Main Medicine Class:: CNS stimulant,Anorexiant   

(benz-FET-uh-meen HIGH-droe-KLOR-ide)
Didrex
Tablets: 25 mg, 50 mg
Class: CNS stimulant/Anorexiant

 Indications Short-term (few weeks) adjunct to diet plan to reduce weight.

 Contraindications Hypersensitivity to sympathomimetic amines; pregnancy; advanced arteriosclerosis; symptomatic cardiovascular disease; moderate to severe hypertension; hyperthyroidism; glaucoma; agitated states; history of drug abuse; during or within 14 days of MAOI use; coadministration with other CNS stimulants.

 Route/Dosage

ADULTS: PO 25 to 50 mg 1 to 3 times/day.

 Interactions

Guanethidine: May decrease hypotensive effect. MAOIs, furazolidone: May cause hypertensive crisis and intracranial hemorrhage. Selective serotonin reuptake inhibitors (eg, fluoxetine): Sympathomimetic effects of benzphetamine may be increased; increased risk of “serotonin syndrome.”

 Lab Test Interferences None well documented.

 Adverse Reactions

CARDIOVASCULAR: Palpitations; tachycardia; arrhythmias; hypertension; hypotension; chest pain. CNS: Hypersensitivity; dizziness; insomnia; euphoria; tremor; headache; restlessness; overstimulation; nervousness; anxiety; agitation. DERMATOLOGIC: Urticaria; rash; erythema; hair loss. EENT: Mydriasis; blurred vision; unpleasant taste. GI: Dry mouth; nausea; diarrhea; constipation; stomach pain. GU: Dysuria; urinary frequency; impotence; menstrual disturbances. HEMATOLOGIC: Bone marrow depression; agranulocytosis; leukopenia. OTHER: Excessive sweating; flushing; myalgia; gynecomastia.

 Precautions

Pregnancy: Category X. Lactation: Undetermined. Children: Not recommended for children < 12 yr. Drug dependence: High potential for dependence and abuse; tolerance may occur. Tartrazine sensitivity: Some products contain tartrazine, which may cause allergic-type reactions in susceptible individuals.

PATIENT CARE CONSIDERATIONS


 Administration/Storage

  • Administer mid-morning or mid-afternoon. Anorexiant effects occur within 1 to 2 hr and last up to 4 hr.
  • Administer last dose several hours before bedtime.
  • Store at room temperature in tightly closed, light-resistant container.

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note cardiovascular disease, hypertension, glaucoma, and history of drug or alcohol abuse.
  • Monitor renal function.
  • Take vital signs and auscultate heart and lungs before administration.
  • Assess mental status. Depressed patients are more likely to misuse drug to induce euphoria and mood elevation.
  • If hypertension, dysrhythmias, marked agitation, restlessness, depression, or other adverse effects occur, withhold medication and notify health care provider.
  • For best results, administer medication concurrently with a program to improve eating habits, increase motivation, and improve self-image.
OVERDOSAGE: SIGNS & SYMPTOMS
  Restlessness, tremor, rapid respirations, tachypnea, dizziness, confusion, mood changes, panic states, dysrhythmias, palpitations, and hypertension or hypotension

 Patient/Family Education

  • Caution patient that this medication must not be taken during pregnancy or when pregnancy is possible. Advise patient to use reliable form of birth control while taking this drug.
  • Remind patient to take medication on empty stomach (1 hr before meal or 2 hr after meal).
  • Instruct patient to avoid taking medication within 6 hr of bedtime because it may cause insomnia.
  • Explain that anorexiant effects are temporary and tolerance to medication and dependence can occur.
  • Instruct patient to notify health care provider immediately if the following symptoms occur: chest pain, palpitations, nervousness, or dizziness.
  • Warn patient not to drive or perform tasks that require mental alertness if dizziness or blurred vision occurs. Notify health care provider of these disturbances.
  • Tell patient to report excessive dryness of mouth, constipation, or prolonged insomnia because dosage may need to be adjusted.
  • Inform patient that weight reduction requires strict adherence to dietary restrictions.

–>

 

Drugs Class ::

(benz-FET-uh-meen HIGH-droe-KLOR-ide)
Didrex
Tablets: 25 mg, 50 mg
Class: CNS stimulant/Anorexiant

Indications for Drugs ::

 Indications Short-term (few weeks) adjunct to diet plan to reduce weight.

Drug Dose ::

 Route/Dosage

ADULTS: PO 25 to 50 mg 1 to 3 times/day.

Contraindication ::

 Contraindications Hypersensitivity to sympathomimetic amines; pregnancy; advanced arteriosclerosis; symptomatic cardiovascular disease; moderate to severe hypertension; hyperthyroidism; glaucoma; agitated states; history of drug abuse; during or within 14 days of MAOI use; coadministration with other CNS stimulants.

Drug Precautions ::

 Precautions

Pregnancy: Category X. Lactation: Undetermined. Children: Not recommended for children < 12 yr. Drug dependence: High potential for dependence and abuse; tolerance may occur. Tartrazine sensitivity: Some products contain tartrazine, which may cause allergic-type reactions in susceptible individuals.

PATIENT CARE CONSIDERATIONS


Drug Side Effects ::

 Adverse Reactions

CARDIOVASCULAR: Palpitations; tachycardia; arrhythmias; hypertension; hypotension; chest pain. CNS: Hypersensitivity; dizziness; insomnia; euphoria; tremor; headache; restlessness; overstimulation; nervousness; anxiety; agitation. DERMATOLOGIC: Urticaria; rash; erythema; hair loss. EENT: Mydriasis; blurred vision; unpleasant taste. GI: Dry mouth; nausea; diarrhea; constipation; stomach pain. GU: Dysuria; urinary frequency; impotence; menstrual disturbances. HEMATOLOGIC: Bone marrow depression; agranulocytosis; leukopenia. OTHER: Excessive sweating; flushing; myalgia; gynecomastia.

Drug Mode of Action ::  

(benz-FET-uh-meen HIGH-droe-KLOR-ide)
Didrex
Tablets: 25 mg, 50 mg
Class: CNS stimulant/Anorexiant

Drug Interactions ::

 Interactions

Guanethidine: May decrease hypotensive effect. MAOIs, furazolidone: May cause hypertensive crisis and intracranial hemorrhage. Selective serotonin reuptake inhibitors (eg, fluoxetine): Sympathomimetic effects of benzphetamine may be increased; increased risk of “serotonin syndrome.”

Drug Assesment ::

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies. Note cardiovascular disease, hypertension, glaucoma, and history of drug or alcohol abuse.
  • Monitor renal function.
  • Take vital signs and auscultate heart and lungs before administration.
  • Assess mental status. Depressed patients are more likely to misuse drug to induce euphoria and mood elevation.
  • If hypertension, dysrhythmias, marked agitation, restlessness, depression, or other adverse effects occur, withhold medication and notify health care provider.
  • For best results, administer medication concurrently with a program to improve eating habits, increase motivation, and improve self-image.
OVERDOSAGE: SIGNS & SYMPTOMS
  Restlessness, tremor, rapid respirations, tachypnea, dizziness, confusion, mood changes, panic states, dysrhythmias, palpitations, and hypertension or hypotension

Drug Storage/Management ::

 Administration/Storage

  • Administer mid-morning or mid-afternoon. Anorexiant effects occur within 1 to 2 hr and last up to 4 hr.
  • Administer last dose several hours before bedtime.
  • Store at room temperature in tightly closed, light-resistant container.

Drug Notes ::

 Patient/Family Education

  • Caution patient that this medication must not be taken during pregnancy or when pregnancy is possible. Advise patient to use reliable form of birth control while taking this drug.
  • Remind patient to take medication on empty stomach (1 hr before meal or 2 hr after meal).
  • Instruct patient to avoid taking medication within 6 hr of bedtime because it may cause insomnia.
  • Explain that anorexiant effects are temporary and tolerance to medication and dependence can occur.
  • Instruct patient to notify health care provider immediately if the following symptoms occur: chest pain, palpitations, nervousness, or dizziness.
  • Warn patient not to drive or perform tasks that require mental alertness if dizziness or blurred vision occurs. Notify health care provider of these disturbances.
  • Tell patient to report excessive dryness of mouth, constipation, or prolonged insomnia because dosage may need to be adjusted.
  • Inform patient that weight reduction requires strict adherence to dietary restrictions.

–>

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

Leave a comment

Your email address will not be published. Required fields are marked *

royalmpo Royalmpo Royalmpo royalmpo royalmpo royalmpo royalmpo https://malangtoday.id/ https://guyonanbola.com/ renunganhariankatolik.web.id royalmpo royalmpo royalmpo dewaslot168 ri188 https://hayzlett.com/c-suite-network/ kingslot jkt88 mpodewa https://going-natural.com/the-story-behind-the-mutilated-scalp-video/ royalmpo/ pisang88/ langkahcurang/ mpohoki/ mpocuan/ royalmpo/ mporoyal/ asiaslot/ rajaslot138/ royalmpo https://hayzlett.com/news/ rajaslot88/ Analisis Scatter Hitam MahjongWays RTP Terukur Kemenangan Puluhan Grid Fase Awal Mahjong Pola Perilaku Pemain Harian Prediksi Strategi Game Terbaik RTP Strategi Target Kemenangan Tekanan Meja Live Kasino Slot Digital Hiburan Ringan Slot Online Tanpa Target Mengelola Mood Pemain Slot https://going-natural.com/my-braid-locs/ https://going-natural.com/kellen-marcus/ narutoslot bangslot royalmpo royalmpo macanasia bosslot slotking gacorway
Strategi Analitik Platform Game Dalam Mengelola Variasi Pola Permainan Online Di Era Windows 12 Pendekatan Data Driven Dalam Memahami Ritme Sistem Permainan Digital Pada Ekosistem Android Modern Studi Dinamika Platform Gaming Melalui Distribusi Kombinasi Simbol Di Tengah Popularitas Xbox Game Pass Analisis Strategi Modern Dalam Mengelola Volatilitas Sistem Permainan Digital Saat Tren Nintendo Kembali Naik Framework Pengolahan Data Gaming Untuk Menjaga Stabilitas Pola Permainan Dalam Era Gemini AI Tools Teori Permainan Mahjong Ways Dalam Analisa Intensitas Sistem RTP Online Pada Perangkat Smartphone Modern Pendekatan Sistematis Dalam Menganalisis Pola Permainan Pada Ekosistem Gaming Setelah Discord Down Model Evaluasi Strategi Platform Game Melalui Observasi Pergerakan Algoritma Setelah Update iOS 26.3.1 Strategi Adaptif Dalam Mengelola Ritme Permainan Pada Platform Digital Dengan Dukungan Windows 12 Pendekatan Data Analitik Untuk Mengidentifikasi Pola Sistem Permainan Mobile Pada Samsung Galaxy S26 Ultra
Studi Adaptasi Strategi Permainan Mahjong Dalam Sistem Platform Digital Di Tengah Tren Nintendo Gaming Analisis Teknologi Gaming Platform Dalam Evolusi Sistem Permainan Berbasis RTP Di Era Gemini AI Pendekatan Sistematik Dalam Analisis Algoritma Permainan Mobile Saat Dark Mode Twitter Kembali Trending Studi Pola Mahjong Ways Dalam Perspektif Strategi Platform Game Pada Perangkat Smartphone Modern Analisis Perkembangan Algoritma Platform Gaming Dalam Sistem Permainan Pada Era Xbox Game Pass Pendekatan Manajemen Risiko Permainan Mobile Dalam Ekosistem Gaming Android Generasi Baru Strategi Pengamatan Sistem Permainan Dalam Lingkungan Platform Game Modern Saat Windows 12 Dibahas Evaluasi Sistem Gaming Platform Dalam Mengelola Variasi Pola Permainan Pada Perangkat Samsung Galaxy Framework Analitik Permainan Digital Dalam Mengelola Variasi Sistem Game Saat Re9 Update Dibahas Gamer Studi Dinamika Platform Game Melalui Pendekatan Analisis Data Di Era Apple Newsroom Digital Model Framework Strategi Permainan Digital Dalam Platform Gaming Berbasis Android Modern Strategi Pengelolaan Sistem Permainan Melalui Pendekatan Data Analitik Pada Infrastruktur Cloud Gaming Analisis Adaptasi Sistem Permainan Dalam Ekosistem Gaming Digital Saat Project Helix Menjadi Sorotan Pendekatan Modern Dalam Analisis Pola Permainan Berbasis Data Saat Gemini AI Digunakan Developer Evaluasi Dinamika Sistem Permainan Digital Melalui Observasi Data Pada Sistem iOS 26.3.1 Studi Struktur Sistem Game Dalam Perspektif Teknologi Gaming Di Tengah Tren Nintendo Global Pendekatan Framework Gaming Dalam Mengelola Pola Permainan Digital Di Tengah Popularitas Mario Day Analisis Perubahan Pola Mahjong Wins Dalam Ekosistem Gaming Modern Saat Re9 Update Diperbincangkan Model Analitik Pola Permainan Mahjong Dalam Sistem Platform Digital Modern Berbasis Android Studi Evolusi Teknologi Gaming Dalam Pengembangan Platform Permainan Pada Sistem Windows 12 Strategi Modern Membaca Sistem Permainan Digital Berbasis Algoritma Pada Infrastruktur Cloud Gaming Evaluasi Sistem Platform Game Dalam Dinamika Permainan Online Pada Era Smartphone Modern Pendekatan Data Platform Dalam Mengidentifikasi Pola Permainan Online Pada Infrastruktur TV App Strategi Pengolahan Data Gaming Dalam Mengelola Pola Permainan RTP Pada Infrastruktur Gaming Cloud Strategi Pengelolaan Pola Permainan Melalui Analisis Platform Digital Saat iPhone Generasi Baru Dirilis Pendekatan Analitik Sistem Game Dalam Mengelola Ritme Permainan Pada Era Xbox Game Pass Strategi Data Driven Dalam Menganalisis Pola Sistem Permainan Digital Pada Infrastruktur Cloud Studi Algoritma Permainan Mahjong Dalam Perspektif Platform Gaming Pada Ekosistem Android Analisis Sistem Permainan Digital Dalam Kerangka Strategi Platform Game Di Era Apple Ecosystem Dinamika Sistem Permainan Mahjong Digital Melalui Observasi Ritme Algoritma Pada Ekosistem Gaming Mobile Modern Pola Mahjong Ways 2 Hari Ini Strategi Malam Mahjong Wins 3 Kisah Sukses Andi Grid Mahjong & Starlight Saksi Mata: Mode Manual Mahjong Wins RTP Bertahap Pragmatic Spiral Pola Mahjong Ways Kurikulum Jackpot Respon Mahjong Wins 3 Lebih Cepat Akselerasi Free Spin Mahjong Wins3